Eric Karas
Insider Reports History
- Location
- San Diego, CA
- Signature
- /s/ Kathleen Scott, Attorney-in-Fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Eric Karas:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ARS Pharmaceuticals, Inc. | Chief Commercial Officer | Common Stock | 10,315 | $175,259 | $16.99 | 01 Jul 2025 | Direct |
| ARS Pharmaceuticals, Inc. | Chief Commercial Officer | Stock option (right to buy) | 240,000 | 02 Jan 2026 | Direct |
Insider Reports Filed by Eric Karas
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SPRY | ARS Pharmaceuticals, Inc. | 02 Jan 2026 | 1 | $0 | 4 | Chief Commercial Officer | 05 Jan 2026, 16:26 |
| SPRY | ARS Pharmaceuticals, Inc. | 01 Jul 2025 | 3 | -$232,360 | 4 | Chief Commercial Officer | 03 Jul 2025, 16:21 |
| SPRY | ARS Pharmaceuticals, Inc. | 18 Jun 2025 | 3 | -$217,500 | 4 | Chief Commercial Officer | 20 Jun 2025, 18:38 |
| SPRY | ARS Pharmaceuticals, Inc. | 20 Mar 2025 | 3 | -$125,000 | 4 | Chief Commercial Officer | 21 Mar 2025, 18:30 |
| SPRY | ARS Pharmaceuticals, Inc. | 02 Jan 2025 | 1 | $0 | 4 | Chief Commercial Officer | 03 Jan 2025, 16:30 |
| SPRY | ARS Pharmaceuticals, Inc. | 02 Dec 2024 | 6 | -$125,423 | 4 | Chief Commercial Officer | 04 Dec 2024, 21:40 |
| SPRY | ARS Pharmaceuticals, Inc. | 18 Sep 2024 | 3 | -$125,000 | 4 | Chief Commercial Officer | 19 Sep 2024, 16:30 |
| SPRY | ARS Pharmaceuticals, Inc. | 19 Aug 2024 | 3 | -$125,000 | 4 | Chief Commercial Officer | 21 Aug 2024, 18:51 |
| SPRY | ARS Pharmaceuticals, Inc. | 02 Jan 2024 | 1 | $0 | 4 | Chief Commercial Officer | 04 Jan 2024, 16:47 |
| SPRY | ARS Pharmaceuticals, Inc. | 03 Jan 2023 | 1 | $0 | 4 | Chief Commercial Officer | 05 Jan 2023, 16:00 |
| SPRY | ARS Pharmaceuticals, Inc. | 08 Nov 2022 | 1 | $0 | 4 | Chief Commercial Officer | 10 Nov 2022, 17:00 |
| SPRY | ARS Pharmaceuticals, Inc. | 08 Nov 2022 | 0 | $0 | 3 | Chief Commercial Officer | 10 Nov 2022, 16:01 |